Related Experiment Video
Updated: May 14, 2025

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Elevated Levels of IL-1Ra, IL-1β, and Oxidative Stress in COVID-19: Implications for Inflammatory Pathogenesis
Alicja Marczewska1, Celina Wojciechowska2, Kamil Marczewski3
1Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Zabrze, Poland.
Insights
COVID-19 patients exhibit elevated levels of interleukin-1 receptor antagonist (IL-1Ra), interleukin-1 beta (IL-1β), and malondialdehyde (MDA). These biomarkers are linked to a more severe disease course and poorer prognosis in coronavirus disease patients.
Area of Science:
- Immunology
- Pathophysiology
- Biomarkers
Background:
- COVID-19, caused by SARS-CoV-2, presents with respiratory and gastrointestinal symptoms, but cardiovascular complications and immune dysregulation are increasingly recognized.
- The SARS-CoV-2 virus can trigger a "cytokine storm," characterized by excessive inflammatory cytokine production and immune system dysfunction.
- Scientific studies indicate a correlation between COVID-19 infection and an increased incidence of cardiovascular events.
Purpose of the Study:
- To investigate the levels of pro- and anti-inflammatory cytokines and oxidative stress markers in COVID-19 patients.
- To determine if specific biomarkers are associated with the severity and prognosis of COVID-19.
- To enhance understanding of the immune system's dysregulation during SARS-CoV-2 infection.
Main Methods:
- A study involving 57 participants, divided into non-COVID (24) and COVID-19 (33) groups.
- Data collection included self-administered questionnaires, anthropometric measurements, and venous blood collection.
- Analysis of pro- and anti-inflammatory cytokines (using Bio-Plex 200), oxidative stress markers, and basic hematological parameters.
Main Results:
- COVID-19 patients showed significantly higher levels of interleukin-1 receptor antagonist (IL-1Ra) and interleukin-1 beta (IL-1β) compared to the non-COVID group.
- Malondialdehyde (MDA), an oxidative stress marker, was also significantly elevated in the COVID-19 group.
- No significant differences were observed in other measured cytokines or oxidative stress markers between the groups.
Conclusions:
- Elevated levels of IL-1Ra, IL-1β, and MDA are associated with the COVID-19 group, supporting their role in disease pathophysiology.
- These elevated biomarkers correlate with a worse clinical course and prognosis in patients with COVID-19.
- Further research into the cytokine storm and immune dysregulation is crucial for identifying at-risk patients and developing targeted therapies and vaccines.
Abstract:
Background: The coronavirus-caused disease (COVID-19), first identified in China in December 2019, has spread worldwide becoming a global pandemic. Although people infected with the SARS-CoV-2 virus presented mainly respiratory and gastrointestinal symptoms, an increase in cardiovascular incidents was observed in several scientific studies. SARS-CoV-2 virus has been shown to disrupt the normal immune response leading to a dysregulation of immune system function and massive production of inflammatory cytokines commonly known as "cytokine storm". Methods: 57 patients eventually participated in the study, assigned to non-COVID (24 patients) and COVID (33 patients) groups. After signing consent to participate in the study, each patient was given a self-administered questionnaire to fill out prior to specimen collection, anthropometric measurements were taken and venous blood was collected for the following determinations: pro- and anti-inflammatory cytokines using a Bio-Plex 200 system, oxidative stress markers and basic hematological blood parameters. Results: showed statistically significant higher values of IL-1Ra and IL-1β in the COVID-19 group. Of the oxidative stress markers, only MDA levels were higher in the COVID-19 group. Conclusions: the results of our study provide evidence and support the occurrence of elevated levels of IL-1Ra, IL-1β and MDA in the COVID-19 group of patients, which are associated with a worse course and prognosis of COVID-19. A better understanding of the pathophysiology and dysregulation of the immune system associated with the cytokine storm is essential to select patients at risk and develop effective drugs and vaccines.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...